Servier Pharmaceuticals LLC and Les Laboratoires Servier to acquire Edgewise Therapeutics, Inc.
Servier Pharmaceuticals LLC and Les Laboratoires Servier have agreed to acquire Edgewise Therapeutics, Inc. in a strategic acquisition valued at $2.65 billion. The trans…
- Buyer
- Servier Pharmaceuticals LLC and Les Laboratoires Servier
- Target
- Edgewise Therapeutics, Inc.
- Deal value
- USD 2,650,000,000
- Deal type
- strategic acquisition
